Tag: de novo genome assembly market share

  • De Novo Genome Assembly Market Growth Outlook From $2.28 Billion In 2026 To $3.96 Billion By 2030

    De Novo Genome Assembly Market Growth Outlook From $2.28 Billion In 2026 To $3.96 Billion By 2030

    Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.

    De Novo Genome Assembly Market Size, Value And Growth Trajectory Through 2030

    The de novo genome assembly market has experienced significant expansion recently. It is projected to grow from $1.99 billion in 2025 to $2.28 billion in 2026, at a compound annual growth rate (CAGR) of 14.6%. The historical growth in this market can be attributed to several factors including the increasing use of next-generation sequencing, the growth of academic research initiatives, the adoption of genome assembly software, a rising demand in clinical diagnostics, and the development of plant and microbial genomics projects.

    The de novo genome assembly market size is projected to experience swift expansion over the coming years. Its valuation is anticipated to reach $3.96 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 14.8%. This projected growth can be ascribed to several factors, including the incorporation of AI into genome assembly processes, the proliferation of cloud-based bioinformatics platforms, an increasing need for rapid custom genome sequencing, the advancement of precision medicine applications, and heightened investment in evolutionary and environmental genomics. Key developments expected during this forecast period encompass automated genome assembly pipelines, sophisticated cloud-based data analysis, the integration of high-throughput sequencing, tailored bioinformatics services, and improvements in visualization and annotation capabilities.

    Get A Free Sample Report With In-Depth Market Insights:

    https://thebusinessresearchcompany.com/sample_request?id=76808656&type=smp&name=De%20Novo%20Genome%20Assembly%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

    De Novo Genome Assembly Market Development Factors: What’s Supporting Demand?

    The escalating demand for personalized medicine is anticipated to drive the expansion of the de novo genome assembly market moving forward. Personalized medicine refers to medical treatments and therapies specifically designed for individual patients, based on their unique genetic makeup, biomarkers, and particular disease characteristics. This demand is on the rise due to advancements in genomic technologies and molecular diagnostics, which enable treatments to be customized according to an individual’s genetic profile, thereby improving outcomes and reducing side effects. De novo genome assembly enhances personalized medicine by reconstructing an individual’s genome from scratch, allowing for the discovery of unique genetic variants and structural alterations that are vital for precision therapies, tailored drug selection, and early disease intervention. For instance, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that the U.S. Food and Drug Administration approved 16 new personalized treatments for rare disease patients in 2023, an increase from six in 2022, comprising seven cancer drugs and three for other diseases and conditions. Thus, the increasing need for personalized medicine is a key factor propelling the growth of the de novo genome assembly market.

    De Novo Genome Assembly Market Segmentation: How Does The Market Break Down By Category?

    The de novo genome assembly market covered in this report is segmented –

    1) By Component: Software, Services

    2) By Organism Type: Human, Animal, Plant, Microbial, Metagenomic Or Mixed Samples

    3) By Technology: Next-Generation Sequencing, Third-Generation Sequencing, Sanger Sequencing, Other Technologies

    4) By Application: Clinical Diagnostics, Agricultural Genomics, Environmental Genomics, Evolutionary Biology, Other Applications

    5) By End-User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Hospitals And Clinics, Other End-Users

    Subsegments:

    1) By Software: Sequence Alignment Software, Genome Assembly Software, Error Correction And Quality Control Software, Visualization And Annotation Software

    2) By Services: Genome Sequencing Services, Data Analysis And Interpretation Services, Custom Genome Assembly Services, Consulting And Bioinformatics Support Services

    De Novo Genome Assembly Market Transformation Trends: What Innovations Are Driving Change?

    Leading companies in the de novo genome assembly market are concentrating on developing innovative solutions, such as high-throughput genome assembly platforms, to accelerate genome reconstruction and enhance accuracy for complex and diverse organisms. These advanced systems integrate long- and short-read sequencing data to rapidly reconstruct complete genomes with high precision, enabling researchers to generate contiguous assemblies more quickly and manage intricate or repetitive genomic regions more efficiently than traditional methods. For instance, in May 2024, Dovetail Genomics Inc., a US-based genomics technology company, introduced the AssemblyLINK Assay, a high-throughput genome assembly platform engineered to expedite genome assembly workflows and boost the accuracy of de novo assemblies. The AssemblyLINK Assay combines proprietary scaffolding technology with existing sequencing data to produce highly contiguous genome assemblies, simplifies data processing through streamlined computational pipelines, and supports a broad spectrum of organisms, ranging from plants and animals to microbial communities. Its distinctive characteristics include compatibility with multiple sequencing platforms, minimized manual intervention, and optimized performance for complex and large genomes, making it especially valuable for biodiversity research and conservation genomics.

    De Novo Genome Assembly Market Key Participants And Competitive Landscape

    Major companies operating in the de novo genome assembly market are Thermo Fisher Scientific Inc., Eurofins Scientific SE, Illumina Inc., QIAGEN N.V., Novogene Corporation, Oxford Nanopore Technologies Ltd., Pacific Biosciences of California Inc., Medgenome labs pvt. Ltd, DNASTAR Inc., Nucleome Informatics Pvt Ltd, Seven Bridges Genomics, DNAnexus Inc., Strand Life Sciences Pvt. Ltd., BaseClear B.V., Dovetail Genomics LLC, SoftGenetics LLC, CosmosID Inc., Microba Life Sciences Ltd., GenomeScan B.V., BGI Genomics Co. Ltd., Macrogen Inc., SeqMatic LLC, NeuGen Biologicals.

    View The Full De Novo Genome Assembly Market Report:

    https://thebusinessresearchcompany.com/report/de-novo-genome-assembly-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

    De Novo Genome Assembly Market Geographic Analysis: Where Is Demand Rising Fastest?

    North America was the largest region in the de novo genome assembly market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the de novo genome assembly market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Reach Out To Our Team:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • De Novo Genome Assembly Market Forecast 2026–2030 Covering Innovation Trends And Competitive Insights

    De Novo Genome Assembly Market Forecast 2026–2030 Covering Innovation Trends And Competitive Insights

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    How Is The Market Size Of The De Novo Genome Assembly Market Expected To Change From 2026 To 2030?

    The de novo genome assembly market has experienced considerable growth in recent years. It is projected to increase from $1.99 billion in 2025 to $2.28 billion in 2026, at a compound annual growth rate (CAGR) of 14.6%. Historically, this growth can be attributed to factors such as the expanding application of next-generation sequencing, the development of academic research initiatives, the widespread adoption of genome assembly software, a heightened demand in clinical diagnostics, and the advancement of plant and microbial genomics projects.

    The de novo genome assembly market is projected to experience substantial expansion in the coming years. It is anticipated to reach a valuation of $3.96 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 14.8%. Key factors driving this growth during the forecast period include the incorporation of AI in genome assembly, the proliferation of cloud-based bioinformatics platforms, the rising need for rapid custom genome sequencing, the increasing use of precision medicine applications, and enhanced investment in evolutionary and environmental genomics. Noteworthy trends anticipated during this period encompass automated genome assembly pipelines, widespread cloud-based data analysis, the integration of high-throughput sequencing, specialized custom bioinformatics services, and advancements in visualization and annotation.

    Access Your Free Sample Report For In-Depth Market Analysis:

    https://www.thebusinessresearchcompany.com/sample_request?id=97375287&type=smp&name=De%20Novo%20Genome%20Assembly%20Market%20Report%202026

    Which Factors Are Influencing The Growth Of The De Novo Genome Assembly Market?

    The increasing requirement for personalized medicine is projected to stimulate the expansion of the de novo genome assembly market in the future. Personalized medicine involves medical interventions and therapies customized for individual patients based on their genetic makeup, biological markers, and specific disease characteristics. The demand for personalized medicine is escalating due to advancements in genomic technologies and molecular diagnostics, which facilitate treatments to be adapted according to an individual’s genetic profile, thereby enhancing outcomes and minimizing adverse effects. De novo genome assembly contributes to personalized medicine by reconstructing an individual’s genome completely, enabling the identification of unique genetic variants and structural changes that inform precise therapies, customized drug selection, and early disease intervention. For instance, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, noted that the U.S. Food and Drug Administration approved 16 new personalized treatments for rare disease patients in 2023, an increase from six in 2022, comprising seven cancer drugs and three for other diseases and conditions. Therefore, the growing need for personalized medicine is propelling the growth of the de novo genome assembly market.

    Which Segment Categories Are Included In The De Novo Genome Assembly Market Segment Analysis?

    The de novo genome assembly market covered in this report is segmented –

    1) By Component: Software, Services

    2) By Organism Type: Human, Animal, Plant, Microbial, Metagenomic Or Mixed Samples

    3) By Technology: Next-Generation Sequencing, Third-Generation Sequencing, Sanger Sequencing, Other Technologies

    4) By Application: Clinical Diagnostics, Agricultural Genomics, Environmental Genomics, Evolutionary Biology, Other Applications

    5) By End-User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Hospitals And Clinics, Other End-Users

    Subsegments:

    1) By Software: Sequence Alignment Software, Genome Assembly Software, Error Correction And Quality Control Software, Visualization And Annotation Software

    2) By Services: Genome Sequencing Services, Data Analysis And Interpretation Services, Custom Genome Assembly Services, Consulting And Bioinformatics Support Services

    Which Trends Are Shaping The De Novo Genome Assembly Market?

    Leading companies in the de novo genome assembly market are primarily focused on creating innovative solutions, such as high-throughput genome assembly platforms, to accelerate genome reconstruction and improve accuracy, especially for complex and diverse organisms. These advanced systems combine both long- and short-read sequencing data to rapidly reconstruct complete genomes with high precision. This approach assists researchers in generating contiguous assemblies more swiftly and managing intricate or repetitive genomic regions with greater efficiency than conventional methods. For instance, in May 2024, Dovetail Genomics Inc., a US-based genomics technology company, introduced the AssemblyLINK Assay. This high-throughput genome assembly platform was designed to expedite genome assembly workflows and enhance the accuracy of de novo assemblies. The AssemblyLINK Assay integrates proprietary scaffolding technology with existing sequencing data to produce highly contiguous genome assemblies, simplifies data processing through streamlined computational pipelines, and supports a wide array of organisms, ranging from plants and animals to microbial communities. Its distinct features include compatibility with multiple sequencing platforms, minimized manual intervention, and optimized performance for complex and large genomes, which makes it particularly valuable for biodiversity research and conservation genomics.

    Who Are The Active Companies Shaping The De Novo Genome Assembly Market?

    Major companies operating in the de novo genome assembly market are Thermo Fisher Scientific Inc., Eurofins Scientific SE, Illumina Inc., QIAGEN N.V., Novogene Corporation, Oxford Nanopore Technologies Ltd., Pacific Biosciences of California Inc., Medgenome labs pvt. Ltd, DNASTAR Inc., Nucleome Informatics Pvt Ltd, Seven Bridges Genomics, DNAnexus Inc., Strand Life Sciences Pvt. Ltd., BaseClear B.V., Dovetail Genomics LLC, SoftGenetics LLC, CosmosID Inc., Microba Life Sciences Ltd., GenomeScan B.V., BGI Genomics Co. Ltd., Macrogen Inc., SeqMatic LLC, NeuGen Biologicals.

    Get The Full De Novo Genome Assembly Market Report:

    https://www.thebusinessresearchcompany.com/report/de-novo-genome-assembly-market-report

    Which Region Is The Top Contributor To The De Novo Genome Assembly Market By Share?

    North America was the largest region in the de novo genome assembly market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the de novo genome assembly market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized De Novo Genome Assembly Market Report For Competitive Insights:

    https://www.thebusinessresearchcompany.com/Customise?id=97375287&name=De%20Novo%20Genome%20Assembly%20Market%20Report%202026&type=smp

    Browse Through More Reports Similar to the Global De Novo Genome Assembly Market 2026, By The Business Research Company

    connected health personal medical devices market report 2026

    https://www.thebusinessresearchcompany.com/report/connected-health-personal-medical-devices-global-market-report

    contract sterilization market report 2026

    https://www.thebusinessresearchcompany.com/report/contract-sterilization-global-market-report

    orthotic insole 3-d printer market report 2026

    https://www.thebusinessresearchcompany.com/report/orthotic-insole-3-d-printer-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model